Victory Capital Management Inc Sigilon Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
$4.42 - $10.61 $270,459 - $649,225
-61,190 Closed
0 $0
Q2 2021

Aug 03, 2021
SELL
$9.15 - $20.17 $35,502 - $78,259
-3,880 Reduced 5.96%
61,190 $657,000
Q1 2021

May 04, 2021
SELL
$18.76 - $40.91 $54,966 - $119,866
-2,930 Reduced 4.31%
65,070 $1.45 Million
Q4 2020

Feb 01, 2021
BUY
$27.6 - $48.03 $1.88 Million - $3.27 Million
68,000 New
68,000 $3.27 Million

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email